Still, clinical decisions depend on approval status, product labeling, side effects, diabetes treatment goals, cardiovascular risk, comorbid conditions, and patient preferences
Unlike older GHRPs that can spike cortisol, prolactin, and appetite, ipamorelin triggers growth hormone release without these unwanted side effects
Weight loss could transform daily life for millions of users, leading to changes in: Food and beverage consumption in both type and quantity Fitness and wellness spending Travel, apparel and personal care categories Even simple steps like living healthier and being more active could significantly impact major consumer markets
The Takeaway Youll probably need to continue taking a GLP-1 weight loss medication even after youve hit your weight loss goal